PCH
DAWN

Polar Capital Holdings’s Day One Biopharmaceuticals DAWN Stock Holding History

Polar Capital Holdings’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,109,177
Closed -$13.7M – 268
2025
Q2 		$13.7M Sell
2,109,177
-240,823
-10% -$1.66M 0.07% 168
2025
Q1 		$18.6M Buy
2,350,000
+2,165,000
+1,170% +$23.3M 0.11% 153
2024
Q4 		$2.34M Hold
185,000
– – 0.01% 267
2024
Q3 		$2.58M Sell
185,000
-750,000
-80% -$10.7M 0.01% 263
2024
Q2 		$12.9M Sell
935,000
-250,000
-21% -$3.66M 0.08% 167
2024
Q1 		$19.6M Sell
1,185,000
-200,000
-14% -$2.99M 0.1% 147
2023
Q4 		$20.2M Sell
1,385,000
-550,000
-28% -$6.67M 0.12% 135
2023
Q3 		$23.7M Buy
1,935,000
+160,385
+9% +$2.09M 0.18% 126
2023
Q2 		$21.2M Buy
1,774,615
+375,067
+27% +$4.9M 0.11% 149
2023
Q1 		$18.7M Hold
1,399,548
– – 0.12% 145
2022
Q4 		$30.1M Buy
1,399,548
+163,973
+13% +$3.36M 0.24% 114
2022
Q3 		$24.7K Buy
1,235,575
+263,879
+27% +$5.61M 0.16% 125
2022
Q2 		$17.4K Buy
+971,696
New +$10M 0.1% 156

Other funds holding DAWN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Polar Capital Holdings's DAWN Position: Q3 2025 in Review

Polar Capital Holdings sold out of Day One Biopharmaceuticals (DAWN) in Q3 2025, closing a stake of 2,109,177 shares — an estimated $13.7M sold.

Polar Capital Holdings first reported a position in DAWN in Q2 2022 and held it in 13 quarters. The position peaked at $30.1M in Q4 2022. 172 funds tracked by Wall St. Rank hold DAWN as of Q3 2025.

  • Polar Capital Holdings reported no remaining Day One Biopharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Polar Capital Holdings sold 2,109,177 Day One Biopharmaceuticals shares in Q3 2025, an estimated $13.7M.
  • Polar Capital Holdings first reported a position in Day One Biopharmaceuticals in Q2 2022 and held it in 13 quarters.
  • Polar Capital Holdings's Day One Biopharmaceuticals position peaked at $30.1M in Q4 2022.
  • 172 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q3 2025.

Based on Polar Capital Holdings's 13F filing for Q3 2025, filed 14 Nov 2025.